Real-world evaluation of compliance and preference in Alzheimer’s disease treatment: an observational study in Taiwan

PURPOSE: Among the medications approved for Alzheimer’s disease (AD), rivastigmine is the only one available as transdermal patch. The aim of this study was to evaluate compliance and caregivers’ preference with oral and transdermal (rivastigmine) monotherapy in patients with mild-to-moderate AD fro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Patient Prefer Adherence
Asıl Yazarlar: Lai, Tzu-Hsien, Wang, Wen-Fu, Yip, Bak-Sau, Yang, Yu-Wan, Peng, Giia-Sheun, Tsai, Shih-Jei, Liao, Yi-Chu, Pai, Ming-Chyi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4821393/
https://ncbi.nlm.nih.gov/pubmed/27099476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S95271
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller